7-azaindoles and use thereof as therapeutic agents

Details for Australian Patent Application No. 2004232483 (hide)

Owner elbion AG

Inventors Kuss, Hildegard; Steinike, Karin; Hofgen, Norbert; Rundfeldt, Chris; Olbrich, Matthias; Egerland, Ute; Schindler, Rudolf

Agent Spruson & Ferguson

Pub. Number AU-B-2004232483

PCT Pub. Number WO2004/094416

Priority 103 18 610.7 24.04.03 DE

Filing date 23 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 19 August 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/094416 Priority application(s): WO2004/094416

19 August 2010 Application Accepted

  Published as AU-B-2004232483

16 December 2010 Standard Patent Sealed

20 January 2011 Alteration of Name

  The name of the patentee has been altered to Biotie Therapies GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232484-5-hydroxyindoles with N-oxide groups and use thereof as a phosphodiesterase 4 inhibitor

2004232482-4-, 6o 7-hydroxyindoles having Noxide groups and the use thereof as therapeutic agents